#Cancer Registry Software Market Forecast

[janetushar1]

Cancer Registry Software Market to Hit $108.38 Billion by 2032

What's Trending in Cancer Registry Software Market?

- Keep Yourself Up-To-Date With The Latest Market Trends.

The global Cancer Registry Software Market was valued at USD 56.42 Billion in 2024 and it is estimated to garner USD 108.38 Billion by 2032 with a registered CAGR of 8.5% during the forecast period 2024 to 2032.

Firstly, the Market report for Cancer Registry Software Market describes the current state of the companies and recommends where it is likely to go next. The report shows the production, revenue, price, market share, and growth rate of each type, mainly divided into Product Types and Product Applications etc.

Additionally, this market report focuses on offering key business measures such as real market moves, market size, qualities, and freedoms, as well as forecast opportunities. This Cancer Registry Software Market report also offers distinctive insights into wealthy regions such as Europe, North America, the Middle East, Africa, and Latin America.

Get a Sample Copy of the Cancer Registry Software Market Report at: https://www.vantagemarketresearch.com/cancer-registry-software-market-1610/request-sample

Top Competitors:

Elekta (Sweden), Electronic Registry Systems Inc. (US), Onco Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), McKesson Corporation (US) and others.

This market report has all the information you need to start or grow your business in the industry. It also includes market drivers, restraints, competitiveness, and geographic estimates, as well as a price and emerging market structure. It is a complete description of a company's business model, benchmarks, consumer preferences, value proposition, and net profit. This comprehensive Cancer Registry Software Market study also sheds light on key techniques that help companies truly assess their customers' buying behavior.

It represents global economic trends between 2024 and 2032. With the help of this market research, top companies can easily make smarter financial decisions. This market analysis is an excellent technique to help companies implement new products. It also includes critical data on major industry topics, including market expansions and evolving market conditions.

This well-researched Cancer Registry Software Market report describes the negative impact COVID-19 is having on various companies and offers companies recommendations on how to recover from the damage suffered by the outbreak as well as the nationwide quarantine. The plan analyzes the company's expectations and priorities, as well as the delivery of all crucial data.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/cancer-registry-software-market-1610/0

This report analyzes key market segments by type, application, and geography. The geographic analysis section covers key regions such as Europe, North America, the Middle East, Africa, and the Asia-Pacific region.

This Cancer Registry Software Market report not only provides valuable data but outlines key goals, pricing strategies, and approaches to help market participants' recommendations in this report will make accelerating economic growth easy. It offers some specific tips and business-related data to help new competitors in the market grow their businesses and diversify their product lines. Companies in the industry should choose tactics that include new product launches, mergers, and partnerships to survive in the competitive marketplace and strengthen their position.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

The quantitative information in this Cancer Registry Software Market analysis helps predict future sales and market penetration. This type of information is based on statistics. The qualitative information provided here will greatly help the key players understand the buyer's opinion of your brand. Improving business goals becomes easy with the information provided in this report.

The industries can draw some conclusions about their original goals. In business. This Cancer Registry Software Market research helps you make assumptions about your competition, customers, and the market in order to make informed business decisions. Additionally, it forecasts the competition in the market for the estimated period of 2024-2032. Effective decision-making in companies leads to business growth and is made possible by this precise market study.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/cancer-registry-software-market-1610

Some of the Key Questions Answered in this Report:

Which are the five top players of the Cancer Registry Software Market?

How will the Cancer Registry Software Market change in the upcoming years?

Which product and application will take a share of the Cancer Registry Software Market?

What will be the CAGR and size of the Cancer Registry Software Market throughout the forecast period?

What are the drivers and restraints of the Cancer Registry Software Market?

Which regional market will show the highest growth?

What is the current industry size, what will the market size be in 2030 and what will the growth rate be?

Who are the major competitors and what is their strategy?

What are the challenges to grow in the industry?

What are the market opportunities and challenges faced by the key vendors?

What are the barriers to entry for new players in the Cancer Registry Software industry?

Check Out More Reports

Global Electric Scooter Market:  Report Forecast by 2032

Global Bakery Processing Equipment Market: Report Forecast by 2032

Global Wheat Powder Grass Market: Report Forecast by 2032

Global Digital Camera Market: Report Forecast by 2032

Global Semiconductor Chips For Automotive Market: Report Forecast by 2032

[sacredcresttribe]

Oncology EMR Software Market Size, Share & Trends Analysis Report By Product ,By End-use, And Segment Forecasts (2024-2031)

Oncology EMR Software Market Overview and Estimation The Oncology EMR (Electronic Medical Records) Software Market Size is poised for steady expansion, driven by growing cancer incidence, the push for value-based care, and the digitization of clinical workflows in oncology centers. According to industry data, the market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2024 through 2031, reflecting strong uptake of specialized EMR solutions that integrate treatment planning, chemotherapy ordering, and oncology-specific analytics.

Oncology EMR Software Latest News and Trends In recent months, several key trends have shaped the Oncology EMR landscape:

Artificial Intelligence & Machine Learning Integration Leading vendors are embedding AI-driven decision-support modules into their EMRs to assist oncologists with protocol selection, early adverse-event detection, and personalized treatment pathways.

Interoperability Accelerators The 21st Century Cures Act in the U.S. and similar initiatives in Europe and Asia have intensified focus on seamless data exchange. Oncology EMRs are increasingly adopting FHIR-based APIs to share patient summaries, radiation therapy plans, and pathology results across hospitals, labs, and registries.

Cloud-Native Deployments A shift from on-premises implementations toward cloud-hosted, subscription-based models is underway—driven by lower upfront costs, faster upgrades, and enhanced remote-access capabilities for multi-site cancer centers.

Tele-oncology Modules COVID-era telehealth uptake has extended to specialty care: vendors now bundle video-consultation, e-consent, and remote symptom-reporting features directly within oncology EMRs, reducing the friction of managing virtual visits.

Real-World Evidence (RWE) Collection Payers and life-science firms are collaborating to use de-identified EMR data for RWE studies. Oncology EMRs are being enhanced to capture structured patient-reported outcomes and longitudinal safety data to support post-market surveillance and value dossiers.

Get Free Sample Pdf : https://www.datamintelligence.com/download-sample/oncology-emr-software-market

Oncology EMR Software Market Segmentation

The Oncology EMR market can be described across multiple dimensions, each demonstrating unique adoption dynamics:

By Component: Solutions (software licenses and perpetual-license packages) constitute the bulk of spending, as oncology centers prefer comprehensive suites that encompass treatment ordering, protocol management, and outcome tracking. Services—primarily customization, integration, and training—account for a significant share of revenue, especially among large academic cancer institutes requiring complex interfacing with laboratory, radiology, and pharmacy systems.

By Deployment Type: Historically, on-premises deployments led the market; however, recent migration trends show cloud-based oncology EMRs capturing nearly two-fifths of new deals by revenue share. Smaller hospitals and outpatient clinics favor cloud subscriptions for lower capital expenditure and predictable operating costs, while top-tier cancer centers continue to invest in on-prem deployments for tighter control over data sovereignty and advanced customization.

By End User: Comprehensive Cancer Centers represent the largest end-user segment, given their high patient volumes and the need for integrated care pathways. Hospitals with designated oncology wings follow closely, leveraging EMRs to coordinate multidisciplinary tumor-board discussions. Specialty outpatient clinics and physician practices collectively make up the remaining slice, adopting lightweight, focused solutions for chemotherapy ordering and patient scheduling.

By Functionality: Core modules—patient demographics, clinical documentation, and order entry—comprise the foundational spend. Advanced functionalities such as chemotherapy regimen libraries, radiation therapy interfacing, and billing-code mapping are driving incremental growth, together representing more than half of total annual license revenues.

Oncology EMR Software Regional Analysis: USA & Japan

United States: The U.S. commands the largest slice—approximately 40% of global Oncology EMR revenues—propelled by a mature healthcare IT infrastructure and robust reimbursement frameworks. The 21st Century Cures Act’s information-blocking rules have incentivized providers to adopt interoperable, certified EMR systems, while Medicare’s Oncology Care Model encourages tight integration between EMR data and value-based payment programs. The U.S. market is projected to grow at a CAGR slightly above the global average, fueled by consolidation among health systems and expansion of outpatient oncology networks.

Japan: Japan represents roughly 12–15% of global Oncology EMR spend, with steady annual growth. Government initiatives such as the “Society 5.0” healthcare vision and the Ministry of Health, Labour and Welfare’s push for digital hospital adoption have accelerated EMR deployments. However, slower legacy-system turnover and stringent data-localization policies temper cloud-migration rates. Local players often partner with global vendors to align with Japan’s unique clinical workflows and language requirements.

Key Highlights from Recent Reports

Oncology EMR solutions with integrated clinical-trial matching capabilities are seeing over 20% higher adoption rates at academic cancer centers.

Cloud-hosted oncology EMRs are reducing total cost of ownership by up to 25%, largely through automated updates and shared-service support models.

Interoperability accelerators such as SMART on FHIR apps are projected to triple in number by 2026, enabling rapid third-party innovation within oncology workflows.

Oncology EMR Software Key Players & Competitive Landscape:

The market is moderately consolidated, with the top five vendors holding a combined share of over 60%. Recent M&A and research highlights include:

Epic Systems – Dominant in large health systems; piloting AI-driven regimen optimization tools.

Oracle Cerner – Following the Cerner acquisition, expanding cloud-native oncology modules.

Allscripts – Partnering with life-sciences firms to integrate RWE-capture features.

GE Healthcare – Leveraging its imaging-informatics heritage to offer unified EMR-PACS-RT workflows.

athenahealth – Gaining traction among specialty clinics with its flexible, subscription-based oncology package.

Additionally, smaller niche vendors such as Aria (Oncology Information System by Varian) and Elekta iO EMR continue to innovate around radiation-oncology integrations and research-data export. 

Conclusion

The Oncology EMR Software Market is on a solid growth trajectory, underpinned by a projected 7.7% CAGR through 2031. As precision oncology, real-world evidence demands, and regulatory imperatives converge, providers will increasingly seek comprehensive, interoperable EMR platforms tailored to the complexities of cancer care. The transition toward cloud-native deployments and AI-enabled decision support will accelerate operational efficiencies, while regional dynamics—particularly in the U.S. and Japan—will shape adoption paths. Overall, the market is set to mature from a basic digital-record offering into a sophisticated, intelligence-driven platform central to the future of oncology treatment delivery.

[thoratketan]

Veterinary Services Strategies In The Global Market: Key Insights From The 2025 Report

The global Patient Registry Software Market, valued at USD 1.75 billion in 2023, is set to experience significant growth, with projections indicating it will reach USD 5.23 billion by 2032. This represents a compound annual growth rate (CAGR) of 12.93% over the forecast period from 2024 to 2032. Increasing adoption of digital health technologies, the need for improved patient data management, and growing emphasis on personalized medicine are key factors driving the rapid expansion of this market.

Get Free Sample Report on Patient Registry Software Market

What is Patient Registry Software?

Patient registry software is a digital tool used by healthcare organizations to collect, store, and analyze comprehensive data on patient populations with specific diseases or conditions. These software solutions are essential in streamlining the collection and analysis of health data, which is crucial for improving patient outcomes, facilitating clinical trials, and enhancing overall healthcare management.

Patient registry software serves various functions, such as improving patient care, supporting research and development efforts, enhancing clinical trial management, and providing data for health policy formulation. It helps healthcare professionals and organizations track patient outcomes, manage chronic diseases, and improve healthcare services. Additionally, it provides valuable insights into population health and the effectiveness of different treatments and interventions.

Key Market Drivers

1. Increasing Need for Efficient Patient Data Management

The growing volume of patient data in healthcare is a major driver of the patient registry software market. Healthcare organizations are increasingly relying on digital solutions to efficiently store, manage, and analyze vast amounts of patient information. Traditional methods of managing patient records are becoming less effective and time-consuming, creating a need for automated, more sophisticated solutions.

Patient registry software simplifies the process of data collection and management by consolidating various data points into a unified, accessible platform. This helps healthcare providers enhance care delivery, reduce errors, and improve operational efficiency. As the healthcare industry moves toward digitization, the demand for patient registry software is expected to rise significantly.

2. Rising Demand for Personalized Medicine

Personalized medicine, also known as precision medicine, tailors medical treatment to the individual characteristics of each patient. This approach relies heavily on the accurate collection and analysis of patient data, which can include information on genetic makeup, lifestyle factors, and environmental influences. Patient registry software plays a vital role in this process by enabling healthcare providers to gather and manage data on individual patients to better understand treatment responses and outcomes.

The increasing adoption of personalized medicine is expected to drive the demand for patient registry software. As healthcare professionals seek more precise treatments for various conditions, particularly chronic diseases, the need for effective patient data management solutions will become more critical.

3. Growing Prevalence of Chronic Diseases

The increasing global burden of chronic diseases, such as diabetes, cardiovascular diseases, cancer, and respiratory disorders, is another major factor propelling the growth of the patient registry software market. Chronic diseases require continuous monitoring and management of patient health, making the use of patient registry software invaluable. These software solutions enable healthcare providers to track patients' conditions over time, monitor their progress, and make informed decisions based on real-time data.

As the global population ages and the prevalence of chronic diseases rises, the demand for tools that support the management and monitoring of these conditions will continue to grow. This trend is expected to drive significant growth in the patient registry software market.

4. Regulatory Support and Government Initiatives

Government initiatives and regulatory support for digital health technologies are also contributing to the market's growth. Governments across the world are encouraging the adoption of electronic health records (EHRs), health information exchanges, and other digital health solutions to improve the quality of care and reduce healthcare costs. Patient registry software plays a central role in these initiatives by helping healthcare providers track patient data, monitor outcomes, and ensure the effective implementation of care programs.

In addition, regulatory bodies are increasingly requiring the use of data-driven approaches to improve patient safety and treatment efficacy. This has created a favorable environment for the widespread adoption of patient registry software, especially in clinical research and regulatory compliance.

5. Advancements in Technology and Integration with Other Healthcare Solutions

Technological advancements in cloud computing, big data analytics, and artificial intelligence (AI) are also enhancing the capabilities of patient registry software. Cloud-based solutions enable easy access to patient data from any location, facilitating real-time updates and collaboration between healthcare providers. Big data analytics and AI can help analyze patient data more efficiently, uncovering patterns and insights that improve patient outcomes and healthcare delivery.

Integration with other healthcare solutions, such as electronic health records (EHRs), laboratory information management systems (LIMS), and clinical decision support systems (CDSS), further enhances the effectiveness of patient registry software. This seamless integration allows healthcare providers to create a comprehensive view of patient health, which is essential for making informed decisions about diagnosis, treatment, and care management.

Market Segmentation

The global patient registry software market is segmented based on type, deployment model, end-user, and region.

By Type: The market is segmented into disease-specific registries, product registries, and health status registries. Disease-specific registries are expected to dominate the market, as they are commonly used for chronic disease management, particularly in oncology, cardiology, and diabetes care.

By Deployment Model: The market includes cloud-based and on-premise solutions. Cloud-based solutions are gaining popularity due to their cost-effectiveness, scalability, and accessibility. These solutions allow healthcare organizations to store and access patient data remotely, which is essential for collaboration among healthcare providers.

By End-User: The market is segmented into hospitals, research organizations, government organizations, and others. Hospitals are expected to hold the largest market share due to the increasing need for patient data management in clinical settings. Research organizations and pharmaceutical companies are also significant users of patient registry software for clinical trials and drug development.

Make Enquiry about Patient Registry Software Market

Key Players

Conclusion

The global patient registry software market is set to experience impressive growth, with an expected increase from USD 1.75 billion in 2023 to USD 5.23 billion by 2032. The rising need for efficient patient data management, the growing prevalence of chronic diseases, advancements in technology, and government initiatives supporting digital health are key factors driving the market's expansion. As healthcare providers increasingly turn to data-driven solutions to improve patient care and treatment outcomes, the patient registry software market will continue to thrive, providing valuable tools for the healthcare industry.

About US:

SNS Insider Is One Of The Leading Market Research And Consulting Agencies That Dominates The Market Research Industry Globally. Our Company's Aim Is To Give Clients The Knowledge They Require In Order To Function In Changing Circumstances. In Order To Give You Current, Accurate Market Data, Consumer Insights, And Opinions So That You Can Make Decisions With Confidence, We Employ A Variety Of Techniques, Including Surveys, Video Talks, And Focus Groups Around The World.

Contact Us:

Jagney Dave - Vice President Of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

[helloancycruzworld]

Cancer Registry Software is a suite of software programs for collecting and processing cancer registry data.

According to this study, over the next five years the Cancer Registry Software market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of…

[sanpdr1994]

Patient Registry Software Market Research Report : Predictable To Exceed Market Income, Shares and Competitive Landscape 2032

The global patient registry software market is estimated at US$ 4.4 Billion while expanding at a CAGR of 8.8% from 2022 to 2032. The market is valued at US$ 1.9 Billion in 2022. The growth of the market can be attributed to the increasing adoption of EHRs in the healthcare sector. The implementation of various favorable government initiatives is expected to strengthen the market in the forecast period.

For instance, in 2016, the U.S introduced Cures Act, which aims to develop medical products and offer innovative technology in the medical sector. Also, the incorporation of AI into EHRs is anticipated to offer various opportunities for expansion. For instance, in October 2019, various scripts along with Northwell Health made an agreement to offer the next-generation electronic health record. The agreement aims to massive revenue generation, thereby, fuelling the market expansion in the coming time.

On the other hand, concerns associated with data privacy and security are expected to hinder the market growth in the forecast period. According to the Identity Theft Resource Center, the U.S recorded about 1.473 breaches in 2019, a rise of 17% against 2018. However, the emergence of cloud-based EHR is anticipated to offer significant opportunities to the market and act as a significant counter to the impeding cause, thereby, supporting the market expansion.

Key Takeaways from the Market Study

The global patient registry market is expected to garner US$ 1.9 Billion in 2022 Global market demand flourished at a 10.4% CAGR from 2015 to 2021 The commercial registry software segment to expand at 8.9% from 2022 to 2032 The US market size to garner US$ 1.5 Billion by 2032 Market in Brazil to value US$ 57 Million from 2022- to 2032 The CAGR of China is expected to be 10.5% from 2022 to 2032 The diabetes registry segment is projected to experience a CAGR of 9.3% from 2022 to 2032 “Increasing chronic diseases across the globe is anticipated to play an important role in driving the market. With the growing cases of cancer, cardiovascular, and diabetes, there has been a notable rise in demand for EHRs, which will impact the market positively in the coming time.”

Competition Analysis

Key players in the global patient registry software market include Dacima Software Inc., Evado eClinical Solutions, IQVIA, Global Vision Technologies Inc., and Invitae. Recent developments among key players are:

In June 2020, ArborMetrix Inc. (US) entered into a strategic partnership with The Society of Interventional Radiology (SIR). The initiative aims to offer the IR Quality Registry to enhance patient care by deploying analytics. In March 2021, ESO Solutions announced a strategic partnership with Virginia EMS Systems (US) to provide an EMS data repository and trauma registry across the state. In April 2021, IQVIA Holdings accomplished the remaining 40% of Q2 solutions from diagnostic information services providers Quest Diagnostics. In December 2020, ImageTrend, Inc. (US) disclosed the latest National Trauma Data Bank (NTDB) Data Dictionary that would be available in the Patient Registry from January 1, 2021. More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global patient registry software market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Type (Public Domain Registry Software, Commercial Registry Software), Disease Area (Diabetes Registry, Cardiovascular Registry, Cancer Registry, Rare Disease/Orphan Disease Registry, Other Chronic Disease Registry), End-User (Government, Commercial), & Regional (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).

[precedenceresearch]

Cancer Registry Software Market Global Sales Are Expected To Reach US$ 117.65 Billion by 2030

Cancer Registry Software Market Global Sales Are Expected To Reach US$ 117.65 Billion by 2030

The global cancer registry software market size is predicted to reach around US$ 117.65 billion by 2030, expanding at an annual CAGR of 9.1 percent, according to a 2022 study by Precedence Research, the Canada-based market Insight Company. The cancer registry software market has been forecast based on volume (kilo tons) and value (US$ Mn) from 2022 to 2030. The report analyses and forecasts the…

[romik-blog]

Cancer Registry Software's are kind of a disease registry that is used to maintain and also add a new cancer incidence reporting system. The cancer registry systems are often used as a resource where information is stored for cancer investigation and the possible causes of cancer.

[market-research-future]

Palliative Care Market Statistics, Overview, Future Outlook and Share Analysis Till 2027

Market Highlights

Increasing incidence of diseases such as cancer, cardiovascular and infective disease are some of the drivers responsible for the market growth of global palliative care market. Other factors such as a growing number of palliative care centers worldwide, expanding aging demographics, increasing number of qualified physicians for palliative care are responsible for the rise in the global palliative market. The main object of palliative care is to enhance personal satisfaction for both the patient and family. This palliative care can be provided at any age and at any phase in a genuine ailment and can be furnished alongside remedial treatment.

But the high cost of treatment, less private or public funding to hospital facilities and other medical centers can be a major restraint for the growth of the global palliative care market.

Regional Analysis

North America is expected to take a major share in the global palliative care market because of good reimbursement and insurance coverage for palliative care services. Countries like Mexico in the Latin America region have a greater number of palliative care centers for children’s. The European market is expected to be the second-largest palliative care market. The market growth in this region can be because of government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of palliative care centers worldwide, extending application for homecare, increasing number of qualified physicians for palliative care center and expanding aging demographics are some of the factors responsible for the rise in global palliative care market. Asia-Pacific is expected to be the fastest-growing palliative care market during the forecast period owing to the increasing prevalence of cardiac diseases, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global palliative care market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global palliative care market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Access Report @ https://www.marketresearchfuture.com/reports/palliative-care-market-6336

Segmentation

The global palliative care market is segmented into type, applications, and end-users. On basis of types, the palliative market is further segmented into private residence care, hospice inpatient care, hospital inpatient care, nursing home, residential facility care and others. Based on application the palliative market is segmented into cancer, cardiac disease such a congestive heart failure, chronic obstructive pulmonary disease, kidney failure, Alzheimer, Parkinson’s, amyotrophic lateral sclerosis and others. On basis of end-user, the palliative market is segmented into hospitals, home care settings, palliative care center, long-term care centers, and rehabilitation centers.

Key Players

Some of the key players in the Global Palliative Care market are Vitas Healthcare Corporation, Skilled Healthcare Group Incorporated, Sunrise Senior Living LLC, Kindred Healthcare Incorporated, Gentiva Health Services Incorporated, Home Instead Senior Care Incorporated, Amedisys Incorporated, Genesis HealthCare Corporation.

Browse Related Reports at:

Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR

Migraine Drugs Market by Type, Drug Class, Growth Analysis Till 2027 | MRFR

Patient Registry Software Market Size, Share, Type, Global Analysis, 2027 | MRFR

[adityarana1687-blog]

Patient Registry Software Market Is Expected To Grow Swiftly By 2027

The global patient registry software market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increasing demand for integrated healthcare systems is fueling the demand for patient registry software. Surmounting burden to curb the healthcare cost is expected to fuel market growth via higher penetration and untapped opportunities. Lack of patient information access was found to be a major barrier for integrating care and proper treatment option in both developed and developing countries, which is further driving the market.

Increasing number of clinical trials by major pharmaceutical and biotechnological companies is expected to drive the patient registry software market over the forecast period. The data obtained via patient registry software helps in tracking patients for clinical trials. Moreover, associated advantages such as increased cost-effectiveness, efficient resource management, and reduced healthcare IT cost, are further widening the scope for market growth. The industry players are also constantly trying to develop advanced registries which can be easily integrated with national registries for a better outcome.

For instance, in September 2019, Elekta signed a distribution agreement with DocSoft for the key patient-specific QA solution software namely EPIgray, MU2Net, and EPIbeam. These software will help to analyze the treatment plan for any diagnosed condition, for future purposes. This agreement is expected to increase the company’s market penetration in the coming years.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/patient-registry-software-market

Further key findings from the report suggest:

Disease registry held the largest revenue share in the patient registry software market owing to the increasing demand to curb the disease burden and stringent regulations by the government bodies

The standalone segment held the largest share in 2019 and is expected to witness a CAGR of over 11.0% by 2027. The growth can be attributed to advanced features offered by the software such as easy data retrieval and auto upgradation

The on-premise segment held the largest revenue share in 2019. This is due to enhanced data security options and ease of access

The public database type segment is expected to show the fastest growth over the forecast period owing to its increased usage for research purposes

The population health management segment held the largest revenue share in 2019. This is due to its growing adoption in developed countries for better patient care

The pharma and medical device companies segment is expected to show the fastest growth over the forecast period, owing to the increasing use of registries by these companies for clinical trial enrollment

Asia Pacific is expected to emerge as the fastest-growing region in this space. Moreover, North America held the largest revenue share due to its established healthcare structure and stringent regulations by the government bodies

Some of the major players include IBM; IQVIA; Elekta AB; McKesson Corporation; Dacima Software Inc.; Phytel, Inc.

Grand View Research has segmented the global patient registry software market based on product, software, database type, deployment model, functionality, end use, and region:

Patient Registry Software Product Outlook (Revenue, USD Million, 2016 - 2027)

Disease Registry

Health Service Registry

Product Registry

Cardiovascular

Diabetes

Cancer

Rare disease

Asthma

Others

Medical Device

Drug

Patient Registry Software Outlook (Revenue, USD Million, 2016 - 2027)

Standalone

Integrated

Patient Registry Software Deployment Model Outlook (Revenue, USD Million, 2016 - 2027)

On Premise

Web/Cloud based

Patient Registry Software Database Type Outlook (Revenue, USD Million, 2016 - 2027)

Commercial

Public

Patient Registry Software Functionality Outlook (Revenue, USD Million, 2016 - 2027)

Population Health Management

Health Information Exchange

Patient Care Management

Point-Of-Care

Medical Research & Clinical Studies

Product Outcome Evaluation

Patient Registry Software End-use Outlook (Revenue, USD Million, 2016 - 2027)

Government & Third Party

Hospitals & Medical Practices

Private Payers

Pharma & Medical Device Companies

Research Organization

Patient Registry Software Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

U.K.

Germany

France

Italy

Spain

Sweden

Japan

China

India

Australia

Singapore

South Korea

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.